Master in Regenerative Medicine

Maastricht University is known for its innovative Problem-Based Learning approach and strong international profile in the Netherlands. Established in 1976, UM encourages small-group tutorials where students actively solve real-world problems, fostering critical thinking, collaboration and self-directed study. Many programs are offered in English, attracting a diverse international student body and creating a multicultural campus atmosphere.

The university emphasizes research in areas such as health, sustainability, governance and data science, and students can engage in interdisciplinary projects with faculty and external partners. Maastricht’s compact city setting supports an integrated student experience, with easy access to cultural activities, internships across the Dutch and European networks, and numerous student organizations that enrich academic and social life.

Graduates benefit from strong international connections, research-led teaching and practical skills developed through PBL. Career services, exchange programs and industry partnerships help students transition into employment or further study. For international students seeking an interactive, research-active university in a historic European city, Maastricht offers a stimulating environment with a clear focus on applied learning and global perspectives.

The Master in Regenerative Medicine at Maastricht University is a 2-year program that focuses on developing methods to repair or regenerate damaged organs and tissues. It's a Master's degree taught in English.

The curriculum provides an overview of the science and technology in Regenerative Medicine, covering topics like multi-disciplinarity, basic science, and translational science. Students will learn how to bring novel inventions to the market and communicate with scientists from different backgrounds.

Graduates can pursue careers as Regenerative Medicine Specialists, Tissue Engineers, Biomedical Researchers, or Medical Device Developers, working in hospitals, research institutions, or biotech companies.